Researchers in California used CAR-T therapy, a type of immunotherapy, to treat a Seattle man suffering from recurrent multifocal glioblastoma, according to a case study published in the Dec. 29 edition of the New England Journal of Medicine. Richard Grady, 50, had been diagnosed with deadly brain cancer that had spread to his spine. He…
Remission Achieved Using CAR-T Cell Therapy for Aggressive Brain Tumors
Actelion and J&J Re-Enter Negotiations
Roundup: 58th Annual Meeting of the American Society of Hematology
Drug Development Scores Big in U.K. Funding Initiative
J&J Eyeing Actelion in Possible Takeover Bid
Lilly, AstraZeneca Alzheimer’s Trial Advancing To Phase 3
Pfizer, Roche, Merck Named Top Biopharma Brands
New York – Pfizer, Roche Group, and Merck & Co., Inc. topped the list of the world’s most valuable biopharmaceutical brands in a new study released by consulting firm InterbrandHealth, a unit of Interbrand. Best Pharma Brands, the consulting group’s inaugural “top 10” biopharma report, was based on global research data and feedback from healthcare professionals. …
MSF Opposes Pfizer Pneumonia Vaccine India Patent Application
New York – Doctors Without Borders/Médecins Sans Frontières (MSF) is challenging Pfizer‘s attempt to patent its Prevenar 13 (PCV13) pneumococcal conjugate vaccine in India so that other manufacturers can produce more affordable versions of the pneumonia vaccine. The move marked the first time a vaccine patent has been challenged in India by a medical organization…
Sanofi Pasteur & Merck to End Joint Vaccines Venture
Kenilworth, NJ – Sanofi Pasteur and Merck plan to end their joint-venture vaccine operations in Europe by the end of this year and to manage their vaccine product portfolios independently. The 50/50 joint venture, Sanofi Pasteur MSD, was created in 1994 to develop and commercialize vaccines originating from both companies’ pipelines within 19 European countries.…
Collaboration Deal to Speed New Drug Development
Cambridge, MA – Novartis has signed a collaboration agreement with clinical data network TriNetX giving its researchers access to real-time data to support clinical study and protocol design, site selection, and patient recruitment. Novartis through its pharmaceutical division develops patent-protected medicines for commercialization in oncology, primary care and specialty care. The TriNetX proprietary network includes…
UK Authorities Fine GSK $54.4 Million
London – GlaxoSmithKline plc has been fined £37.6 million ($54.4 million) by the U.K.’s Competition and Markets Authority (CMA) for stalling the potential market entry of generic competitors to its Seroxat anti-depressant drug, also know as paroxetine. Several other pharmaceutical companies also were fined for anti-competitive conduct and agreements in relation to the supply of…